Estrogen receptor beta decreases survival of p53-defective cancer cells after DNA damage by impairing G2/M checkpoint signaling

@article{Thomas2010EstrogenRB,
  title={Estrogen receptor beta decreases survival of p53-defective cancer cells after DNA damage by impairing G2/M checkpoint signaling},
  author={C. Thomas and A. Strom and K. Lindberg and J. Gustafsson},
  journal={Breast Cancer Research and Treatment},
  year={2010},
  volume={127},
  pages={417-427}
}
  • C. Thomas, A. Strom, +1 author J. Gustafsson
  • Published 2010
  • Biology, Medicine
  • Breast Cancer Research and Treatment
  • Estrogen receptor beta (ERβ) inhibits proliferation in different cellular systems by regulating components of the cell cycle machinery. Eukaryotic cells respond to DNA damage by arresting in G1, S, or G2 phases of the cell cycle to initiate DNA repair. Most tumor cells due to disruptions in the p53-dependent G1 pathway are dependent on S-phase and G2/M checkpoints to maintain genomic integrity in response to DNA damage. We report that induction of ERβ expression causes abrogation of the S-phase… CONTINUE READING
    45 Citations
    ERβ Sensitizes NSCLC to Chemotherapy by Regulating DNA Damage Response
    • 10
    • PDF
    ERβ alters the chemosensitivity of luminal breast cancer cells by regulating p53 function
    • 11
    • PDF
    The p53-estrogen receptor loop in cancer.
    • 43
    Somatic loss of estrogen receptor beta and p53 synergize to induce breast tumorigenesis
    • 16
    • PDF
    ERβ Regulates NSCLC Phenotypes by Controlling Oncogenic RAS Signaling
    • 13
    • PDF

    References

    SHOWING 1-10 OF 46 REFERENCES
    Therapeutic Exploitation of Checkpoint Defects in Cancer Cells Lacking p53 Function
    • 81
    • Highly Influential
    Chk1 Suppresses a Caspase-2 Apoptotic Response to DNA Damage that Bypasses p53, Bcl-2, and Caspase-3
    • 215
    Recent Advances in Cancer Therapy Targeting Proteins Involved in DNA Double-Strand Break Repair
    • 186
    • PDF
    Tumor Suppressor p53 Is Required To Modulate BRCA1 Expression
    • 84
    • Highly Influential
    • PDF